Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) (HIV/TB)
Integral Research of the Managing and Treatment of the Infection With Human Immunodeficiency (VIH) /Human Immunodeficiency Syndrome(SIDA) Co-infection With Latent Tuberculosis Infection. A Multidisciplinary and Interinstitucional Approach
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
A PHASE4 clinical study on Human Immunodeficiency Virus (HIV) and Latent Tuberculosis Infection (LTI), this trial is ongoing. The trial is conducted by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran and has accumulated 6 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Oct 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Oct 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Instituto Nacional de Enfermedades Respiratorias
- Instituto Nacional de Salud Publica, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .